for our eyes wrote:
That's a reasonable question. For a practical answer, look at Mark Daly's article.
http://www.bbc.com/news/uk-scotland-32983932He experienced a very significant (and lasting) improvement in performance level even though his blood scores came out clean enough not to raise red flags under the bio profile test.
There are several reasons for this. One is that the profile is generous in setting a theoretical "natural" hemoglobin volume limit and EPO (or transfusion) is very useful in allowing you to approximate that limit. Microdosing properly avoids raising red flags on the ratio scores that catch people who are clumsy in going on and off EPO (or in blood doping).
We have advanced beyond simply testing for EPO as a substance but still far from preventing its use to drastically improve performance.
I saw his BBC bit, and while I thought it was interesting, it isn't good science to apply his results to elites. Mark Daly isn't representative of an elite, and his preparation for his experiment isn't representative of an elite's training. Not to mention he's a sample size of 1.
And I find it odd that, if dodging a positive test is so easy, you have almost a third of the London winners with "suspicious" results.
And if the purpose of microdosing is to approach the "upper limit" of the theoretical natural, and lots of athletes are microdosing, then shouldn't you have a lot of athletes in the upper range? Given the wealth of data that has suddenly become available, it should be easy to see if there are.
I'm skeptical of what's being reported. I like the transparency, but there are some tougher questions that need to be asked.
For example, a "suspicious" result is being defined as a 1 in 100 chance of occuring naturally, correct? If an athlete is tested 100 times over a period of time, doesn't statistics say we should expect the athlete to have a suspicious result at some point? In fact, wouldn't it be unusual for the athlete NOT to have a suspicious result?